Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$0.42 - $0.72 $1,480 - $2,537
-3,524 Reduced 86.78%
537 $0
Q3 2023

Nov 03, 2023

SELL
$0.6 - $1.53 $291 - $743
-486 Reduced 10.69%
4,061 $2,000
Q2 2023

Aug 09, 2023

BUY
$1.05 - $1.63 $1,928 - $2,994
1,837 Added 67.79%
4,547 $5,000
Q1 2023

May 09, 2023

SELL
$1.2 - $2.73 $2,116 - $4,815
-1,764 Reduced 39.43%
2,710 $3,000
Q4 2022

Feb 13, 2023

SELL
$1.71 - $3.61 $8,411 - $17,757
-4,919 Reduced 52.37%
4,474 $8,000
Q3 2022

Oct 27, 2022

BUY
$1.9 - $8.63 $6,302 - $28,625
3,317 Added 54.59%
9,393 $23,000
Q2 2022

Aug 01, 2022

SELL
$2.13 - $9.01 $51,793 - $219,087
-24,316 Reduced 80.01%
6,076 $15,000
Q1 2022

May 11, 2022

BUY
$6.28 - $15.59 $3,133 - $7,779
499 Added 1.67%
30,392 $242,000
Q4 2021

Feb 11, 2022

SELL
$14.7 - $28.67 $393,195 - $766,865
-26,748 Reduced 47.22%
29,893 $456,000
Q3 2021

Nov 10, 2021

BUY
$24.31 - $33.6 $194,528 - $268,867
8,002 Added 16.45%
56,641 $1.61 Million
Q2 2021

Aug 05, 2021

BUY
$26.09 - $40.4 $10,592 - $16,402
406 Added 0.84%
48,639 $1.64 Million
Q1 2021

Apr 28, 2021

BUY
$33.06 - $56.93 $490,015 - $843,816
14,822 Added 44.36%
48,233 $1.84 Million
Q4 2020

Feb 04, 2021

BUY
$39.09 - $57.4 $231,139 - $339,406
5,913 Added 21.5%
33,411 $1.4 Million
Q3 2020

Nov 10, 2020

BUY
$28.43 - $44.67 $595,921 - $936,327
20,961 Added 320.65%
27,498 $1.19 Million
Q2 2020

Aug 07, 2020

BUY
$11.71 - $30.29 $2,002 - $5,179
171 Added 2.69%
6,537 $198,000
Q1 2020

May 13, 2020

BUY
$7.64 - $27.5 $12,071 - $43,450
1,580 Added 33.01%
6,366 $87,000
Q4 2019

Feb 04, 2020

BUY
$15.02 - $20.57 $37,369 - $51,178
2,488 Added 108.27%
4,786 $77,000
Q3 2019

Nov 08, 2019

BUY
$18.85 - $27.5 $32,195 - $46,970
1,708 Added 289.49%
2,298 $44,000
Q3 2018

Nov 01, 2018

BUY
$7.54 - $18.31 $4,448 - $10,802
590 New
590 $10,000
Q1 2018

May 08, 2018

SELL
$4.69 - $10.05 $9,380 - $20,100
-2,000 Closed
0 $0
Q4 2017

Feb 02, 2018

BUY
$7.86 - $9.99 $15,720 - $19,980
2,000
2,000 $18,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.